Your browser doesn't support javascript.
loading
Rationale, Design, and Methodology of the MORCOR-TURK Trial: Predictors of In-hospital MORtality in CORonary Care Patients in Turkey.
Kahraman, Fatih; Ersoy, Ibrahim; Yilmaz, Ahmet Seyda; Atici, Adem; Tekin, Alpin Mert; Açar, Burak; Kaya, Çaglar; Kara, Faruk; Kurt, Feyza; Avci Demir, Fulya; Çerik, Idris Bugra; Yilmaz, Ishak; Adali, Mehmet Koray; Yeni, Mehtap; Tascanov, Mustafa Begenç; Yenerçag, Mustafa; Sahin, Mürsel; Düz, Ramazan; Gülasti, Sevil; Ömür, Sefa Erdi; Topuz, Sahin; Hidayet, Siho; Kaçmaz, Yücel; Aygül, Nazif.
Afiliación
  • Kahraman F; Department of Cardiology, Kütahya Evliya Çelebi Training and Research Hospital, Kütahya, Turkey.
  • Ersoy I; Department of Cardiology, Faculty of Medicine, Afyonkarahisar Science of Health University, Afyonkarahisar, Turkey.
  • Yilmaz AS; Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.
  • Atici A; Department of Cardiology, Faculty of Medicine, Medeniyet University, Istanbul, Turkey.
  • Tekin AM; Department of Cardiology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Açar B; Department of Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Kaya Ç; Department of Cardiology, Edirne Sultan 1. Murat State Hospital, Edirne, Turkey.
  • Kara F; Department of Cardiology, Ahi Evren Training and Research Hospital, Trabzon, Turkey.
  • Kurt F; Department of Cardiology, Yalova State Hospital, Yalova, Turkey.
  • Avci Demir F; Department of Cardiology, Private Medical Park Hospital, Antalya, Turkey.
  • Çerik IB; Department of Cardiology, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey.
  • Yilmaz I; Department of Cardiology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
  • Adali MK; Department of Cardiology, Faculty of Medicine, Pamukkale University, Denizli, Turkey.
  • Yeni M; Department of Cardiology, Isparta City Hospital, Isparta, Turkey.
  • Tascanov MB; Department of Cardiology, Faculty of Medicine, Harran University, Sanliurfa, Turkey.
  • Yenerçag M; Department of Cardiology, Faculty of Medicine, Ordu University, Ordu, Turkey.
  • Sahin M; Department of Cardiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Düz R; Department of Cardiology, Faculty of Medicine, Van Yüzüncü Yil University, Van, Turkey.
  • Gülasti S; Department of Cardiology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.
  • Ömür SE; Department of Cardiology, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey.
  • Topuz S; Department of Cardiology, Tekirdag City Hospital, Tekirdag, Turkey.
  • Hidayet S; Department of Cardiology, Faculty of Medicine, Inönü University, Malatya, Turkey.
  • Kaçmaz Y; Department of Cardiology, Kesan State Hospital, Edirne, Turkey.
  • Aygül N; Department of Cardiology, Faculty of Medicine, Selçuk University, Konya, Turkey.
Anatol J Cardiol ; 27(5): 258-265, 2023 05.
Article en En | MEDLINE | ID: mdl-37119186
BACKGROUND: Coronary care units are sophisticated clinics established to reduce deaths due to acute cardiovascular events. Current data on coronary care unit mortality rates and predictors of mortality in Turkey are very limited. The MORtality predictors in CORonary care units in TURKey (MORCOR-TURK) trial was designed to provide information on the mortality rates and predictors in patients followed in coronary care units in Turkey. METHODS: The MORCOR-TURK trial will be a national, observational, multicenter, and noninterventional study conducted in Turkey. The study population will include coronary care unit patients from 50 centers selected from all regions in Turkey. All consecutive patients admitted to coronary care units with cardiovascular diagnoses between 1 and 30 September 2022 will be prospectively enrolled. All data will be collected at one point in time, and the current clinical practice will be evaluated (ClinicalTrials.gov number NCT05296694). In the first step of the study, admission diagnoses, demographic characteristics, basic clinical and laboratory data, and in-hospital management will be assessed. At the end of the first step, the predictors and rates of in-hospital mortality will be documented. The second step will be in cohort design, and discharged patients will be followed up till 1 year. Predictors of short- and long-term mortality will be assessed. Moreover, a new coronary care unit mortality score will be generated with data acquired from this cohort. RESULTS: The short-term outcomes of the study are planned to be shared by early 2023. CONCLUSION: The MORCOR-TURK trial will be the largest and most comprehensive study in Turkey evaluating the rates and predictors of in-hospital mortality of patients admitted to coronary care units.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pacientes / Mortalidad Hospitalaria Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Anatol J Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pacientes / Mortalidad Hospitalaria Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Anatol J Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía